Home Biosimilar Antibodies Immunology & Inflammation Immunology & Inflammation related antibody Quavonlimab (Anti-CTLA-4 / CD152) For research use only.
Not for use in humans.

Quavonlimab (Anti-CTLA-4 / CD152)

Synonyms: MK-1308

Quavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.

Quavonlimab (Anti-CTLA-4 / CD152)

Purity & Quality Control

Choose Selective Immunology & Inflammation related Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Quavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.

Product Details

CAS No. 2254059-25-9
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Quavonlimab (Anti-CTLA-4 / CD152) | Quavonlimab (Anti-CTLA-4 / CD152) supplier | purchase Quavonlimab (Anti-CTLA-4 / CD152) | Quavonlimab (Anti-CTLA-4 / CD152) cost | Quavonlimab (Anti-CTLA-4 / CD152) manufacturer | order Quavonlimab (Anti-CTLA-4 / CD152) | Quavonlimab (Anti-CTLA-4 / CD152) distributor